369.1K
Downloads
194
Episodes
A weekly podcast for pharmacists, physicians, physician assistants, and nurse practitioners who are interested in learning more about clinical pharmacology topics. To claim pharmacology CE credit or to get a copy of presentation slides, visit https://ce.mayo.edu/pharmacypodcast. Produced by @MayoMedEd. Hosted by @garrett_schramm.
Episodes
Apr 14, 2021
Apr 14, 2021
32 min
Kyle Wamsley, Pharm.D. (@KyleWamsley1) discusses current literature surrounding the use of oral antimicrobials in the treatment of infective endocarditis (IE), identifies specific patient populations in whom it may be appropriate to consider oral therapy for the treatment of IE, and outlines oral antimicrobial regimens which may be most appropriate for use in the treatment of IE.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Apr 7, 2021
Apr 7, 2021
41 min
Ashley Otto, Pharm.D., BCPS describes the pathophysiology of non-pulmonary clinical manifestations in cystic fibrosis (CF), reviews guideline recommendations and primary literature to manage non-pulmonary CF complications, and selects appropriate treatment options for patients with non-pulmonary CF complications.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Mar 31, 2021
Mar 31, 2021
39 min
Cassandra Schmitt, Pharm.D. (@cjschmitt2) describes the differences between thrombolytic agents used for the treatment of ischemic stroke, discusses the literature examining the efficacy and safety outcomes of tenecteplase, and identifies the role of tenecteplase in ischemic stroke thrombolysis.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Mar 24, 2021
Mar 24, 2021
40 min
Shannon Piche, Pharm.D., BCPS describes the incidence and clinical manifestation of PICS, reviews literature examining the long term implications of critical illness, and discusses current strategies to address care gaps related to PICS symptom recognition and management.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Mar 17, 2021
Mar 17, 2021
32 min
Allison Golbach, Pharm.D., BCPS (@AllisonGPharmD) reviews the definition, background, and measurement of financial toxicity, discusses the impact of financial toxicity on patients’ clinical outcomes, and identifies methods to help patients make informed decisions about their oncology care.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Mar 10, 2021
Mar 10, 2021
33 min
Kellyn Engstrom, Pharm.D., MPH (@KellynEPharmD) reports on current guideline recommendations and gaps in evidence for the treatment of status epilepticus, interprets recent evidence regarding conventional antiepileptic utilization in status epilepticus, and lists three considerations in applying new evidence for status epilepticus treatment into clinical practice.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Mar 3, 2021
Mar 3, 2021
32 min
Mikhaila Rice, Pharm.D., BCPS (@MikhailaPharmD) reviews chronic lymphocytic leukemia diagnosis and historical treatment options, describes the pharmacology of Bruton tyrosine kinase inhibitors and venetoclax, and discusses the use of targeted agents as first line therapy for chronic lymphocytic leukemia.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Feb 24, 2021
Feb 24, 2021
33 min
Madison Fazio, Pharm.D. (@madison_fazio) discusses new guideline recommendations for the management of gout, reviews the literature contributing to the new gout recommendations, and recognizes patients that would benefit from newer gout therapies based on guideline recommendations.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Feb 17, 2021
Feb 17, 2021
40 min
Natalie Haddad, Pharm.D. (@NatalieHaddadRx) explains the mechanism of action of midodrine, reviews the current evidence for midodrine and its impact on vasopressor discontinuation and identifies midodrine’s role in therapy for vasopressor discontinuation.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Feb 10, 2021
Feb 10, 2021
36 min
Danielle Hess, Pharm.D. (@dhess_09) describes the potential effects of bariatric surgery on drug pharmacotherapy measures due to altered gastrointestinal anatomy, reviews literature pertaining to warfarin use after bariatric surgery and discusses safety and efficacy of direct-acting oral anticoagulants (DOACs) following bariatric surgery.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.